Twin Capital Management Inc. Raises Stake in Medtronic PLC $MDT

Twin Capital Management Inc. raised its stake in Medtronic PLC (NYSE:MDT) by 41.3% in the third quarter, HoldingsChannel reports. The institutional investor owned 35,306 shares of the medical technology company’s stock after buying an additional 10,311 shares during the quarter. Twin Capital Management Inc.’s holdings in Medtronic were worth $3,363,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of MDT. Brighton Jones LLC increased its holdings in Medtronic by 1,368.0% during the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock valued at $3,194,000 after acquiring an additional 37,265 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in Medtronic by 9.6% during the 2nd quarter. Sivia Capital Partners LLC now owns 4,356 shares of the medical technology company’s stock valued at $380,000 after buying an additional 381 shares during the last quarter. SteelPeak Wealth LLC acquired a new position in shares of Medtronic in the second quarter worth $218,000. Maryland State Retirement & Pension System boosted its stake in shares of Medtronic by 3.8% during the second quarter. Maryland State Retirement & Pension System now owns 62,331 shares of the medical technology company’s stock valued at $5,433,000 after acquiring an additional 2,302 shares during the last quarter. Finally, Blair William & Co. IL increased its position in Medtronic by 0.5% during the 2nd quarter. Blair William & Co. IL now owns 82,679 shares of the medical technology company’s stock worth $7,207,000 after purchasing an additional 442 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on MDT. Piper Sandler reiterated a “neutral” rating on shares of Medtronic in a report on Monday, January 5th. UBS Group reiterated a “neutral” rating and issued a $104.00 price target on shares of Medtronic in a report on Wednesday. Wells Fargo & Company assumed coverage on Medtronic in a report on Friday, January 30th. They set an “overweight” rating and a $114.00 price objective on the stock. Daiwa Securities Group upped their target price on Medtronic from $104.00 to $117.00 and gave the company a “buy” rating in a research note on Tuesday, November 25th. Finally, Citigroup assumed coverage on Medtronic in a report on Tuesday. They issued a “buy” rating and a $117.00 price target for the company. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $110.67.

Medtronic Stock Down 0.1%

Shares of NYSE:MDT opened at $102.89 on Friday. Medtronic PLC has a 1 year low of $79.55 and a 1 year high of $106.33. The stock has a 50-day simple moving average of $99.40 and a 200-day simple moving average of $96.10. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.80 and a current ratio of 2.42. The stock has a market capitalization of $131.91 billion, a P/E ratio of 27.73, a PEG ratio of 2.71 and a beta of 0.71.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.05. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The company had revenue of $8.96 billion during the quarter, compared to the consensus estimate of $8.86 billion. During the same period in the previous year, the firm earned $1.26 earnings per share. Medtronic’s revenue for the quarter was up 6.6% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. Equities analysts forecast that Medtronic PLC will post 5.46 earnings per share for the current year.

Medtronic Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 16th. Shareholders of record on Friday, December 26th were paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Friday, December 26th. Medtronic’s payout ratio is currently 76.55%.

Medtronic Profile

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).